Búsqueda de: revascularization

Si no está conforme con los resultados, inténtelo de nuevamente.
Chronic Coronary Syndromes

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues...
Dr. Omar Tupayachi -
Ir
Structural heart disease

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common,...
Dr. Juan Manuel Pérez -
Ir
Infrapatellar

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within...
Dr. Juan Manuel Pérez -
Ir
Femoropopliteal

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves...
Dr. Juan Manuel Pérez -
Ir
Coronary disease

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with...
Dr. Juan Manuel Pérez -
Ir
Acute coronary syndromes

Physiology-Guided Complete Revascularization in Elderly Adults with Complex Disease

Complete revascularization in patients with acute myocardial infarction (AMI) and multivessel coronary artery disease has consistently shown...
Dr. Omar Tupayachi -
Ir
Acute coronary syndromes

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), the optimal timing...
Dr. Juan Manuel Pérez -
Ir
Acute coronary syndromes

EuroPCR 2025 | 10-Year Follow-up of DANAMI-3-PRIMULTI: Complete vs. Culprit-Only Revascularization in STEMI with Multivessel Disease

The DANAMI-3-PRIMULTI trial included 627 patients with ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD),...
solaci -
Ir